# Cystic fibrosis-related diabetes is associated with reduced airway microbial diversity

**Authors:** Stefanie Diemer, Katja Kozjek, Lisa I. Påhlman

PMC · DOI: 10.1186/s12931-026-03598-2 · Respiratory Research · 2026-02-27

## TL;DR

People with cystic fibrosis and diabetes have less diverse airway bacteria, likely due to poor lung function rather than diabetes itself.

## Contribution

This study identifies reduced airway microbial diversity in cystic fibrosis-related diabetes, linking it primarily to lung function decline.

## Key findings

- CFRD group had significantly lower lung function and higher IL-1β levels compared to non-CFRD.
- CFRD sputum microbiome showed reduced bacterial diversity, but this was mainly due to lung function differences.
- Abiotrophia, Anaeroglobus, and Escherichia-Shigella were enriched in CFRD, while Neisseria, Prevotella, and Streptococcus were more common in non-CFRD.

## Abstract

Cystic fibrosis (CF) is a genetic disorder characterized by chronic airway inflammation and lung function decline. CF-related diabetes (CFRD) is the main extrapulmonary complication and it is tightly linked to an impaired lung function, but the underlying mechanisms behind these observations are incompletely understood. In the present study, we aimed to compare airway microbiome compositions between pwCF with and without CFRD.

Sputum samples from pwCF with and without CFRD were analysed for inflammatory cytokines using MesoScale assays and total bacterial load using quantitative PCR of the 16s rRNA gene. Bacterial sputum microbiomes were analysed with 16s rRNA sequencing and characterized based on richness and evenness. Bray-Curtis was used to determine the distance in microbiome compositions between samples.

Forty-four pwCF were included, of which 59% were diagnosed with CFRD. The CFRD group had significantly lower lung function and elevated sputum levels of IL-1β compared to pwCF without CFRD. The CFRD sputum microbiome was characterized by reduced bacterial diversity, but this association was attenuated after adjusting for lung function. The distance in microbiome composition did not differ between groups. Abiotrophia, Anaeroglobus and Escherichia-Shigella were significantly enriched in the CFRD group, while Neisseria, Prevotella and Streptococcus were more abundant in pwCF without CFRD.

CFRD is associated with impaired lung function, elevated airway inflammation, and a sputum microbiome characterized by reduced bacterial diversity and a more dysbiotic composition. The decreased microbial diversity observed in pwCF with CFRD was predominantly driven by impaired lung function rather than by CFRD itself.

## Linked entities

- **Diseases:** cystic fibrosis (MONDO:0009061), CF-related diabetes (MONDO:7770003), CFRD (MONDO:7770003)

## Full-text entities

- **Genes:** IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, SMG1 (SMG1 nonsense mediated mRNA decay associated PI3K related kinase) [NCBI Gene 23049] {aka 61E3.4, ATX, LIP}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, CFTR (CF transmembrane conductance regulator) [NCBI Gene 1080] {aka ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR}
- **Diseases:** P. aeruginosa infection (MESH:D011552), respiratory diseases (MESH:D012140), airway inflammation (MESH:D007249), Chronic infection (MESH:D000088562), lung function decline (MESH:D055370), asthma (MESH:D001249), CF (MESH:D003550), airway dysbiosis (MESH:D064806), pulmonary (MESH:D008171), diabetes (MESH:D003920), infected (MESH:D007239), Reduced lung function (MESH:D001523), function (MESH:D003291), chronic obstructive pulmonary disease (MESH:D029424), type 2 diabetes (MESH:D003924), impaired lung function (MESH:D003072), genetic disorder (MESH:D030342), CF lung disease (MESH:C563237)
- **Chemicals:** ETI (-), bicarbonate (MESH:D001639), carbon (MESH:D002244), Elexacaftor (MESH:C000629074), H2O (MESH:D014867), chloride (MESH:D002712), insulin (MESH:D007328), blood glucose (MESH:D001786), Glucose (MESH:D005947), DTT (MESH:D004229)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Streptococcus (genus) [taxon 1301], Anaeroglobus [taxon 156454], Homo sapiens (human, species) [taxon 9606], Pseudomonas aeruginosa (species) [taxon 287], Mus musculus (house mouse, species) [taxon 10090], Staphylococcus aureus (species) [taxon 1280], Prevotella (genus) [taxon 838], Abiotrophia (genus) [taxon 46123], Neisseria (genus) [taxon 482], Shigella (genus) [taxon 620], gut metagenome (species) [taxon 749906]
- **Mutations:** F508del

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12958520/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12958520/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12958520/full.md

---
Source: https://tomesphere.com/paper/PMC12958520